DOAJ Open Access 2023

S216: CD47/PD-L1 BISPECIFIC ANTIBODY (IBI322) IN ANTI-PD-1 OR PD-L1 TREATMENT-RESISTANT CLASSICAL HODGKIN LYMPHOMA: A PHASE I STUDY

Huilai Zhang Jingwei Yu He LI Wenbin Qian Xibin Xiao +10 lainnya

Penulis (15)

H

Huilai Zhang

J

Jingwei Yu

H

He LI

W

Wenbin Qian

X

Xibin Xiao

Q

Qingqing Cai

Y

Yao Liu

Y

Yu Zhang

L

Liling Zhang

L

Ling Qin

H

Hui Zhou

X

Xiaoyi Tang

Y

Yingmei Guo

H

Hui Zhou

T

Ting Niu

Format Sitasi

Zhang, H., Yu, J., LI, H., Qian, W., Xiao, X., Cai, Q. et al. (2023). S216: CD47/PD-L1 BISPECIFIC ANTIBODY (IBI322) IN ANTI-PD-1 OR PD-L1 TREATMENT-RESISTANT CLASSICAL HODGKIN LYMPHOMA: A PHASE I STUDY. https://doi.org/10.1097/01.HS9.0000967776.81028.41

Akses Cepat

Informasi Jurnal
Tahun Terbit
2023
Sumber Database
DOAJ
DOI
10.1097/01.HS9.0000967776.81028.41
Akses
Open Access ✓